Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01622816 · ClinicalTrials.gov registry record
Comparing Visual Acuity Measurements (How Well You Can See) Using a Standard ETDRS Chart & a Handheld ETDRS Chart
A clinical trial of Diabetic Retinopathy, sponsored by Julia Haller.
- Completed
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT01622816 is a study of Diabetic Retinopathy that has completed, run by Julia Haller. The registered enrollment target is 70 participants, below the 1,675-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01622816, a study of Diabetic Retinopathy, has completed, sponsored by Julia Haller.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparing visual acuity measurements (measurements of how well you can see) using a standard ETDRS (Early Treatment Diabetic Retinopathy Study) chart and a handheld ETDRS chart
Conditions Studied
Study Locations (1)
Pennsylvania
- Mid Atlantic Retina- Wills Eye Institute - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01622816
The ClinicalTrials.gov registry entry for NCT01622816 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,675-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (96% lower). The listed sponsor is Julia Haller, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Retinopathy appearing as the primary indexed condition, and to 0 interventions.
NCT01622816 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01622816 about?
NCT01622816 is a clinical study titled "Comparing Visual Acuity Measurements (How Well You Can See) Using a Standard ETDRS Chart & a Handheld ETDRS Chart". Comparing visual acuity measurements (measurements of how well you can see) using a standard ETDRS (Early Treatment Diabetic Retinopathy Study) chart and a handheld ETDRS chart
What is the current status of trial NCT01622816?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2012-03. Estimated completion is 2014-03.
What conditions does trial NCT01622816 study?
This clinical trial studies the following conditions: Diabetic Retinopathy.
Who is sponsoring clinical trial NCT01622816?
This trial is sponsored by Julia Haller, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01622816 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fenofibrate for Prevention of DR Worsening
RECRUITING · Phase 3
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
RECRUITING
-
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
RECRUITING · NA
-
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
RECRUITING · Phase 2
-
Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.